In Vitro Analysis of a Transcription Termination Site for RNA Polymerase II DEBRA K

Total Page:16

File Type:pdf, Size:1020Kb

In Vitro Analysis of a Transcription Termination Site for RNA Polymerase II DEBRA K MOLECULAR AND CELLULAR BIOLOGY, Nov. 1990, p. 5782-5795 Vol. 10, No. 11 0270-7306/90/115782-14$02.00/0 Copyright © 1990, American Society for Microbiology In Vitro Analysis of a Transcription Termination Site for RNA Polymerase II DEBRA K. WIEST' 2 AND DIANE K. HAWLEY' 3* Institute of Molecular Biology' and Departments ofBiology2 and Chemistry, University of Oregon, Eugene, Oregon 97403 Received 11 June 1990/Accepted 8 August 1990 Transcription from the adenovirus major late (ML) promoter has previously been shown to pause or terminate prematurely in vivo and in vitro at a site within the first intron of the major late transcription unit. We are studying the mechanism of elongation arrest at this site in vitro to define the DNA sequences and proteins that determine the elongation behavior of RNA polymerase II. Our assay system consists of a nuclear extract prepared from cultured human cells. With standard reaction conditions, termination is not observed downstream of the ML promoter. However, in the presence of Sarkosyl, up to 80% of the transcripts terminate 186 nucleotides downstream of the start site. Using this assay, we showed that the DNA sequences required to promote maximal levels of termination downstream of the ML promoter reside within a 65-base-pair region and function in an orientation-dependent manner. To test whether elongation complexes from the ML promoter were functionally homogeneous, we determined the termination efficiency at each of two termination sites placed in tandem. We found that the behavior of the elongation complexes was different at these sites, with termination being greater at the downstream site over a wide range of Sarkosyl concentrations. This result ruled out a model in which the polymerases that read through the first site were stably modified to antiterminate. We also demonstrated that the ability of the elongation complexes to respond to the ML termination site was promoter specific, as the site did not function efficiently downstream of a heterologous promoter. Taken together, the results presented here are not consistent with the simplest class of models that have been proposed previously for the mechanism of Sarkosyl-induced termination. Regulation of transcription is known to be an important tion system to study the mechanism of transcription termi- mechanism for altering gene expression during differentia- nation in vitro downstream of the adenovirus major late tion and development in eucaryotic cells. Much of this (ML) promoter. In vivo, transcription from the ML pro- regulation occurs at the level of initiation of transcription by moter pauses or terminates within intron 1 of the major late RNA polymerase II (pol II), the nuclear enzyme that tran- transcription unit at late but not early times during adenovi- scribes protein-encoding genes. Recently, research in a rus infection (29, 32). In vitro, extended pausing or termina- number of laboratories has demonstrated that pol II is also tion at this site is not observed under standard reaction subject to regulation after initiation by selective arrest of conditions when the ML promoter is transcribed in nuclear transcription elongation at specific sites within genes (re- extracts prepared from uninfected human cells. However, in viewed in reference 50). Perhaps the best evidence for such the of more than the regulation has been obtained through the study of expression presence Sarkosyl, 80% of transcripts of the c-myc gene in humans and mice. In those systems, initiated at the ML promoter indefinitely paused or termi- changes in the ability of transcription elongation to proceed nated at this site (16). past the 3' end of exon 1 have been shown to correlate with The finding that Sarkosyl promoted termination at a spe- changes in c-myc expression that occur during differentiation cific site downstream ofthe ML promoter was an outcome of and with the abnormal expression of c-myc in some Burkitt's experiments originally designed to test the usefulness of lymphoma cells (reviewed by C. A. Spencer and M. Grou- Sarkosyl as a means of blocking transcription initiation (16, dine, Adv. Cancer Res., in press). Evidence for regulated 17). Sarkosyl had previously been shown to prevent initia- blocks to transcription elongation has also been obtained for tion but to allow elongation by purified pol II in vitro at other cellular genes, including the mouse c-myb, hamster concentrations that dissociated most DNA-binding proteins c-fos, Drosophila hsp70, and human and mouse adenosine (14). Consistent with that observation, Sarkosyl was found deaminase genes and viral genes encoded by simian virus 40, to inhibit pol II transcription initiation in a nuclear extract polyomavirus, human adenovirus, minute virus of mice, and system as well but not to inhibit elongation generally (16). human immunodeficiency virus (2, 7, 11, 13, 18, 22, 27, 29, These initial observations have now been confirmed and 38, 41, 48). extended by a number ofgroups studying initiation in vitro at To date, most of the studies of potential attenuation sites the ML promoter, as well as at other class II promoters, and for pol II transcription have relied primarily on nuclear the usefulness of this approach for limiting transcription by run-on assays and isolation of prematurely terminated or pol II to a single round of initiations is well documented (4, processed transcripts from injected oocytes or virus-infected 5, 8, 15, 28, 47). Moreover, other groups have now demon- cells. Neither approach is amenable to detailed mechanistic strated Sarkosyl-dependent termination or pausing by pol II studies. We used a cell-free, promoter-dependent transcrip- at other sites corresponding to transcriptional attenuation sites in vivo (37, 38, 40). The method may, therefore, have a general usefulness in characterizing the elongation reaction * Corresponding author. as well. However, it remains to be determined whether the 5782 VOL. 10, 1990 TERMINATION IN VITRO BY RNA POLYMERASE II 5783 mechanism of induction of termination by Sarkosyl is the from pAdTr to the HindIII site ofplasmids pPT+ and pP+T, same at these various sites. respectively. To make plasmids pP+TT.2 and pP+T+T, we Because it is an unusually strong promoter in vitro, the first digested pAdT and pAdT+, respectively, with SmaI ML promoter has been studied extensively and was used in and PvuII to generate a DNA fragment containing all the the original isolation and characterization of transcription adenovirus sequences from each plasmid flanked by vector factors (10, 31, 42). For these reasons, and because of the DNA. The DNA fragment was isolated and inserted between high efficiency of termination we have observed, this homol- the promoter and terminator sites in pP+T, using a BamHI ogous system is uniquely suited for the study of the proteins site that had first been filled in with the Klenow fragment of and DNA sequences responsible for termination by pol II in DNA polymerase I to make it compatible with the blunt- vitro. As a first step, we began to define the specific DNA ended restriction fragment. sequences that contribute to termination downstream of the To make the plasmid pMPT+, we first constructed the ML promoter and to test several simple models for the plasmid pM,0, which contains mouse 3-globin DNA from mechanism of Sarkosyl-induced termination. the ClaI site at -110 to the BamHI site at +475 ligated to the AccI and BamHI sites of pTZ18U. These 1-globin sequences MATERIALS AND METHODS were obtained from the plasmid pMH,8 (33; gift from R. Myers, University of California, San Francisco) and con- Plasmid constructions. The plasmid pMLH1, which con- tained an 8-bp BglII linker at +26. To construct pMPT+, tains adenovirus DNA sequences from -260 to +536 with pMIO was restricted at a PstI site immediately upstream of respect to the ML cap site, has been described previously the ,-globin sequences, and the 3' overhanging ends were (17). pMLH3, which was used as a source of promoter- or removed with T4 DNA polymerase. This DNA was then terminator-containing DNA during construction of several of restricted with BglII, and the resulting DNA fragment con- the plasmids described below, contains ML promoter se- taining ,B-globin sequences from -110 to +26 was ligated to quences from -260 to + 198 and was made by ligating a pAdT+ restricted with SmaI and BamHI. PstI-HindIII DNA fragment from pMLH1 to the PstI and Plasmids pPC28T and pPC246T were derivatives of plas- HindIII sites in the vector pTZ19U (U.S. Biochemicals). mids we obtained in making a series of 3' deletions of the The plasmid pPT was made in two steps. First, a DNA G-less cassette sequence in pMLC2AT (45). The construc- fragment containing adenovirus sequences from the HaeIII tion of those plasmids will be presented in greater detail site at + 153 to the HindIII site at + 193 was purified and elsewhere. The parent plasmids used in this study contained ligated to the vector pTZ18U (U.S. Biochemicals) restricted ML promoter DNA from -260 to + 10 followed by 28 or 246 with HincII and HindIII. The resulting plasmid was called bp of the original G-less cassette sequence inserted into the pAdT. Next, a 337-base-pair (bp) fragment was purified after vector pTZ18U. A HindIII fragment containing adenovirus digestion of pMLH3 with EcoRI and PvuII. The EcoRI site sequences from pAdTr was ligated to each parent plasmid at was located upstream of adenovirus sequences, and the a HindIII site located 4 bp downstream of the end of the PvuII site was at +33 with respect to the ML cap site. This G-less cassette. fragment was ligated to pAdT restricted with EcoRI and The dideoxy-chain termination DNA-sequencing method SmaI to create pPT. To make the plasmid pP+T, we of Sanger et al.
Recommended publications
  • Chapter 18 Regulation of Gene Expression Regulation of Gene Expression • Important for Cellular Control and Differentiation
    Chapter 18 Regulation of Gene Expression Regulation of Gene Expression • Important for cellular control and differentiation. • Understanding “expression” is a “hot” area in Biology. General Mechanisms 1. Regulate Gene Expression 2. Regulate Protein Activity Operon Model • Jacob and Monod (1961) - Prokaryotic model of gene control. • Always on the National AP Biology exam! Operon Structure 1. Regulatory Gene 2. Operon Area a. Promoter b. Operator c. Structural Genes Gene Structures Regulatory Gene • Makes Repressor Protein which may bind to the operator. • Repressor protein blocks transcription. Promoter • Attachment sequence on the DNA for RNA polymerase to start transcription. Operator • The "Switch”, binding site for Repressor Protein. • If blocked, will not permit RNA polymerase to pass, preventing transcription. Structural Genes • Make the enzymes for the metabolic pathway. Lac Operon • For digesting Lactose. • Inducible Operon - only works (on) when the substrate (lactose) is present. If no Lactose • Repressor binds to operator. • Operon is "off”, no transcription, no enzymes made If Lactose is absent If Lactose is present • Repressor binds to Lactose instead of operator. • Operon is "on”, transcription occurs, enzymes are made. If Lactose is present Enzymes • Digest Lactose. • When enough Lactose is digested, the Repressor can bind to the operator and switch the Operon "off”. Net Result • The cell only makes the Lactose digestive enzymes when the substrate is present, saving time and energy. Animation • http://www.biostudio.com/d_%20Lac%20Ope ron.htm trp Operon • Makes/synthesizes Tryptophan. • Repressible Operon. – Predict how it is different from the inducible operon… If no Tryptophan • Repressor protein is inactive, Operon "on” Tryptophan made. • “Normal” state for the cell.
    [Show full text]
  • RNA-Based Regulation of Genes of Tryptophan Synthesis and Degradation, in Bacteria
    REVIEW RNA-based regulation of genes of tryptophan synthesis and degradation, in bacteria CHARLES YANOFSKY Department of Biological Sciences, Stanford University Stanford, California 94305, USA ABSTRACT We are now aware that RNA-based regulatory mechanisms are commonly used to control gene expression in many organisms. These mechanisms offer the opportunity to exploit relatively short, unique RNA sequences, in altering transcription, translation, and/or mRNA stability, in response to the presence of a small or large signal molecule. The ability of an RNA segment to fold and form alternative hairpin secondary structures—each dedicated to a different regulatory function—permits selection of specific sequences that can affect transcription and/or translation. In the present paper I will focus on our current understanding of the RNA-based regulatory mechanisms used by Escherichia coli and Bacillus subtilis in controlling expression of the tryptophan biosynthetic operon. The regulatory mechanisms they use for this purpose differ, suggesting that these organisms, or their ancestors, adopted different strategies during their evolution. I will also describe the RNA-based mechanism used by E. coli in regulating expression of its operon responsible for tryptophan degradation, the tryptophanase operon. Keywords: trp operon; trp suboperon; aro supraoperon; tna operon; transcription attenuation; T box regulation; tryptophan as a regulatory signal; tRNATrp as a regulatory signal; peptidyl-tRNA; ribosome mediated regulation INTRODUCTION A second regulatory lesson learned over the years is that information within mRNAs, or other RNAs, as well as small Studies over the past 50+ years have revealed that metabolites and other molecules—in addition to DNA and optimization of gene expression has been a major evolu- proteins—often provides specific regulatory signals, or tionary objective for most species.
    [Show full text]
  • Chapter 3. the Beginnings of Genomic Biology – Molecular
    Chapter 3. The Beginnings of Genomic Biology – Molecular Genetics Contents 3. The beginnings of Genomic Biology – molecular genetics 3.1. DNA is the Genetic Material 3.6.5. Translation initiation, elongation, and termnation 3.2. Watson & Crick – The structure of DNA 3.6.6. Protein Sorting in Eukaryotes 3.3. Chromosome structure 3.7. Regulation of Eukaryotic Gene Expression 3.3.1. Prokaryotic chromosome structure 3.7.1. Transcriptional Control 3.3.2. Eukaryotic chromosome structure 3.7.2. Pre-mRNA Processing Control 3.3.3. Heterochromatin & Euchromatin 3.4. DNA Replication 3.7.3. mRNA Transport from the Nucleus 3.4.1. DNA replication is semiconservative 3.7.4. Translational Control 3.4.2. DNA polymerases 3.7.5. Protein Processing Control 3.4.3. Initiation of replication 3.7.6. Degradation of mRNA Control 3.4.4. DNA replication is semidiscontinuous 3.7.7. Protein Degradation Control 3.4.5. DNA replication in Eukaryotes. 3.8. Signaling and Signal Transduction 3.4.6. Replicating ends of chromosomes 3.8.1. Types of Cellular Signals 3.5. Transcription 3.8.2. Signal Recognition – Sensing the Environment 3.5.1. Cellular RNAs are transcribed from DNA 3.8.3. Signal transduction – Responding to the Environment 3.5.2. RNA polymerases catalyze transcription 3.5.3. Transcription in Prokaryotes 3.5.4. Transcription in Prokaryotes - Polycistronic mRNAs are produced from operons 3.5.5. Beyond Operons – Modification of expression in Prokaryotes 3.5.6. Transcriptions in Eukaryotes 3.5.7. Processing primary transcripts into mature mRNA 3.6. Translation 3.6.1.
    [Show full text]
  • Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the Tna Operon of Escherichia Coli
    JOURNAL OF BACTERIOLOGY, Aug. 1995, p. 4451–4456 Vol. 177, No. 15 0021-9193/95/$04.0010 Copyright 1995, American Society for Microbiology Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the tna Operon of Escherichia coli CHARLES YANOFSKY* AND VIRGINIA HORN Department of Biological Sciences, Stanford University, Stanford, California 94305-5020 Received 13 March 1995/Accepted 27 May 1995 The growth-inhibiting drug bicyclomycin, known to be an inhibitor of Rho factor activity in Escherichia coli, was shown to increase basal level expression of the tryptophanase (tna) operon and to allow growth of a tryptophan auxotroph on indole. The drug also relieved polarity in the trp operon and permitted growth of a trp double nonsense mutant on indole. Nine bicyclomycin-resistant mutants were isolated and partially characterized. Recombination data and genetic and biochemical complementation analyses suggest that five have mutations that affect rho, three have mutations that affect rpoB, and one has a mutation that affects a third locus, near rpoB. Individual mutants showed decreased, normal, or increased basal-level expression of the tna operon. All but one of the resistant mutants displayed greatly increased tna operon expression when grown in the presence of bicyclomycin. The tna operon of the wild-type drug-sensitive parent was also shown to be highly expressed during growth with noninhibitory concentrations of bicyclomycin. These findings demonstrate that resistance to this drug may be acquired by mutations at any one of three loci, two of which appear to be rho and rpoB. Zwiefka et al. (24) found that the antibiotic bicyclomycin segment and interacts with the transcribing RNA polymerase (bicozamycin), an inhibitor of the growth of several gram- molecule, causing it to terminate transcription (7, 9).
    [Show full text]
  • I = Chpt 15. Positive and Negative Transcriptional Control at Lac BMB
    BMB 400 Part Four - I = Chpt 15. Positive and Negative Transcriptional Control at lac B M B 400 Part Four: Gene Regulation Section I = Chapter 15 POSITIVE AND NEGATIVE CONTROL SHOWN BY THE lac OPERON OF E. COLI A. Definitions and general comments 1. Operons An operon is a cluster of coordinately regulated genes. It includes structural genes (generally encoding enzymes), regulatory genes (encoding, e.g. activators or repressors) and regulatory sites (such as promoters and operators). 2. Negative versus positive control a. The type of control is defined by the response of the operon when no regulatory protein is present. b. In the case of negative control, the genes in the operon are expressed unless they are switched off by a repressor protein. Thus the operon will be turned on constitutively (the genes will be expressed) when the repressor in inactivated. c. In the case of positive control, the genes are expressed only when an active regulator protein, e.g. an activator, is present. Thus the operon will be turned off when the positive regulatory protein is absent or inactivated. Table 4.1.1. Positive vs. negative control BMB 400 Part Four - I = Chpt 15. Positive and Negative Transcriptional Control at lac 3. Catabolic versus biosynthetic operons a. Catabolic pathways catalyze the breakdown of nutrients (the substrate for the pathway) to generate energy, or more precisely ATP, the energy currency of the cell. In the absence of the substrate, there is no reason for the catabolic enzymes to be present, and the operon encoding them is repressed. In the presence of the substrate, when the enzymes are needed, the operon is induced or de-repressed.
    [Show full text]
  • Binds Multiple Sites Within the Aroh and Trp Operators
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Escherichia cod tryptophan repressor binds multiple sites within the aroH and trp operators Andrew A. Kumamoto, ~ William G. Miller, 2 and Robert P. GunsalusL2 1Molecular Biology Institute and the 2Department of Microbiology, University of Califomia, Los Angeles, Califomia 90024 USA DNase I footprinting and methylation protection studies have been used to analyze the binding of Escherichia coli Trp repressor to the trpR, aroH, and trp operators. The methylation protection assay shows that Trp repressor binds in two successive major grooves of the trpR operator, three successive major grooves of the aroH operator, and four successive major grooves of the trp operator. The simplest model that explains the difference in Trp repressor interaction at the three operators is that the aroH and trp operators are composed of multiple, helically stacked binding sites. When viewed in three dimensions, each site is positioned on a different face of the DNA, and together process up the surface of the DNA helix. Analysis of a deletion derivative of the trp operator supports this model. [Key Words" Trp repressor; aroH operator; trp operator; repressor binding] Received February 23, 1987; revised version accepted June 6, 1987. The Trp repressor of Escherichia coli coordinately regu- and by the isolation of constitutive mutations within lates the expression of the trp, aroH, and trpR operons in the trp operator {Bennett and Yanofsky 1978). These op- response to the intracellular levels of L-tryptophan erator constitutive mutations map at positions -16, (Cohen and Jacob 1959; Brown 1968; Rose et al.
    [Show full text]
  • The Tryptophan Biosynthetic Pathway Trp Biosynthesis Is a Biologically Expensive, Complicated Process
    E. Coli Trp repressor The tryptophan repressor proteins The trp repressor proteins regulate transcription of several diferent operons located at separate sites on the E. coli chromosome. In addition to the trp operon, this repressor represses transcription of aroH, a single-gene operon that encodes an enzyme required for the synthesis of all aromatic amino acids, and trpR, another single-gene operon encoding the trp repressor itself. Such coordinately regulated operons constitute a regulon. Although all three operons in this regulon are repressed by the trp repressor, the extent of repression varies from about twofold for the aroH operon to seventyfold for the trp operon. This variation results from diferences in the afnity of trp repressor for the specific operator in each of these operons, diferences in the position of the operators relative to the −10 and −35 sequences of each promoter, and diferences in the strengths of the three promoters. Thus the specific nucleotide sequences of the promoters and operators in a regulon allow the same repressor to diferentially regulate transcription of the component operons. The tryptophan biosynthetic pathway Trp biosynthesis is a biologically expensive, complicated process. In fact, the products of four other pathways are essential contributors of carbon or nitrogen during tryptophan formation. Thus, the principal pathway precursor, chorismate, is also the precursor of the other aromatic amino acids, phenylalanine and tyrosine, as well as serving as the precursor of p- aminobenzoic acid and several other metabolites. In addition, glutamine, phosphoribosylpyrophosphate, and L-serine contribute nitrogen and/or carbon during tryptophan formation. FIGURE 1. The genes, enzymes, and reactions of the tryptophan biosynthetic pathway.
    [Show full text]
  • Open Smarajit Mondal Dissertation
    The Pennsylvania State University The Graduate School Eberly College of Science REGULATION OF TRANSCRIPTION BY NusA AND NusG IN Bacillus subtilis A Dissertation in Biochemistry, Microbiology, and Molecular Biology by Smarajit Mondal © 2016 Smarajit Mondal Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2016 The dissertation of Smarajit Mondal was reviewed and approved* by the following: Paul Babitzke Professor Biochemistry and Molecular Biology Dissertation Adviser Chair of Committee David S. Gilmour Professor of Biochemistry and Molecular Biology Joseph C. Reese Professor of Biochemistry and Molecular Biology Katsuhiko Murakami Professor of Biochemistry and Molecular Biology Philip C. Bevilacqua Professor Chemistry Scott B. Selleck Head of the Department of Biochemistry and Molecular Biology *Signatures are on file in the Graduate School. ii ABSTRACT Transcription in bacteria is regulated at the level of initiation, elongation and termination. Although the regulation of transcriptional initiation is well studied, the regulation of elongation and termination are not well understood. This thesis focuses on understanding the role of NusA on intrinsic termination and the role of NusG on RNA polymerase pausing using genomic, biochemical and computational analyses. Tight regulation of transcription termination is required to maintain proper levels of gene expression in bacteria, because termination failure abolishes operon boundaries, leading to misregulation of downstream genes. NusA is a negative transcription elongation factor that was known to cause a slight stimulation of termination at intrinsic terminators in vitro, but its impact on termination and global gene expression in vivo was not known. In this thesis, I describe the mapping of intrinsic terminators genome wide in B subtilis and measure the effect of NusA on the efficiency of these terminators in vivo using a novel high resolution 3’ end-mapping technique coupled with mRNA profiling.
    [Show full text]
  • Mechanisms of Prokaryotic Gene Regulation
    Overview: Conducting the Genetic Orchestra • Prokaryotes and eukaryotes alter gene expression in response to their changing environment • In multicellular eukaryotes, gene expression regulates development and is responsible for differences in cell types • RNA molecules play many roles in regulating gene expression in eukaryotes Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings Fig. 18-1 1 Concept 18.1: Bacteria often respond to environmental change by regulating transcription • Natural selection has favored bacteria that produce only the products needed by that cell • A cell can regulate the production of enzymes by feedback inhibition or by gene regulation • Gene expression in bacteria is controlled by the operon model Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings Fig. 18-2 Precursor Feedback inhibition trpE gene Enzyme 1 trpD gene Regulation of gene expression Enzyme 2 trpC gene trpB gene Enzyme 3 trpA gene Tryptophan (a) Regulation of enzyme (b) Regulation of enzyme activity production 2 Operons: The Basic Concept • A cluster of functionally related genes can be under coordinated control by a single on-off “switch” • The regulatory “switch” is a segment of DNA called an operator usually positioned within the promoter • An operon is the entire stretch of DNA that includes the operator, the promoter, and the genes that they control Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings • The operon can be switched off by a protein repressor • The repressor prevents gene transcription by binding to the operator and blocking RNA polymerase • The repressor is the product of a separate regulatory gene Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings 3 • The repressor can be in an active or inactive form, depending on the presence of other molecules • A corepressor is a molecule that cooperates with a repressor protein to switch an operon off • For example, E.
    [Show full text]
  • The Trp Operon (BIOT 4006: Genetics and Molecular Biology)
    The trp Operon (BIOT 4006: Genetics and Molecular Biology) Dr. Saurabh Singh Rathore Department of Biotechnology MGCU Introduction • Synthesis of the enzymes involved in the biosynthesis of tryptophan is controlled by the trptophan/trp operon in E. coli. • Charles Yanofsky and others have studied in detail the working of the five structural genes and the close regulatory elements of the trp operon. • The precursor for biosynthesis of the amino acid tryptophan is “chorismic acid”. • The five structural genes of the trp operon code for enzymes required for conversion of chorismic acid to tryptophan. • There are two levels of regulation of this operon: 1. Repression: works at the level of transcription initiation 2. Attenuation: works at the level of transcription termination Repression of the trp operon • The repression regulation works negatively. • The trpR gene coding for repressor of trp operon is distantly located from the operon itself. • P1 is for primary promoter region and it contains the operator (O) region. • P2 is a weak promoter found at that end of the trpD gene which is more far from the operator. Its function is to increase the basal transcription level of the trpC, trpB & trpA genes. • There are two termination regions, namely t and t’ placed downstream to the trpA gene. The trpL denotes a region for a mRNA leader sequence (162 nucleotides in length). E. Coli trp operon organization • The biosynthesis of tryptophan is shown at the bottom. • The five structural genes coding for enzymes needed for tryptophan biosynthesis are: trpE, trpD, trpC, trpB & trpA. • trpL is the regulatory segment. • The gene lengths and the intergenic distances are shown as bp’s.
    [Show full text]
  • Regulation of Gene Expression
    CAMPBELL BIOLOGY IN FOCUS URRY • CAIN • WASSERMAN • MINORSKY • REECE 15 Regulation of Gene Expression Lecture Presentations by Kathleen Fitzpatrick and Nicole Tunbridge, Simon Fraser University © 2016 Pearson Education, Inc. SECOND EDITION Overview: Beauty in the Eye of the Beholder . Prokaryotes and eukaryotes alter gene expression in response to their changing environment . Multicellular eukaryotes also develop and maintain multiple cell types © 2016 Pearson Education, Inc. Concept 15.1: Bacteria often respond to environmental change by regulating transcription . Natural selection has favored bacteria that produce only the gene products needed by the cell . A cell can regulate the production of enzymes by feedback inhibition or by gene regulation . Gene expression in bacteria is controlled by a mechanism described as the operon model © 2016 Pearson Education, Inc. Figure 15.2 Precursor Genes that encode enzymes 1, 2, and 3 Feedback trpE inhibition Enzyme 1 trpD Regulation of gene expression Enzyme 2 trpC – trpB – Enzyme 3 trpA Tryptophan (a) Regulation of enzyme (b) Regulation of enzyme activity production © 2016 Pearson Education, Inc. Operons: The Basic Concept . A group of functionally related genes can be coordinately controlled by a single “on-off switch” . The regulatory “switch” is a segment of DNA called an operator, usually positioned within the promoter . An operon is the entire stretch of DNA that includes the operator, the promoter, and the genes that they control © 2016 Pearson Education, Inc. The operon can be switched off by a protein repressor . The repressor prevents gene transcription by binding to the operator and blocking RNA polymerase . The repressor is the product of a separate regulatory gene © 2016 Pearson Education, Inc.
    [Show full text]
  • Escherichia Coli Model System for Studying Gene Expression & Protein Misfolding Dr
    Escherichia coli Model System for Studying Gene Expression & Protein Misfolding Dr. Abdelaziz D. Bior (Cheyney University of Pennsylvania) Dr. Paul Freimuth, (Laboratory , Brookhaven National Laboratory, Department of Biosciences) Highlighted Topics of the Talk • The BNL Synchrotron (NSLS-II) and u6lizaon • Background • The Invented cloning technique at BNL • Hypothesis • Differences in gene expression and protein synthesis between Prokaryo6c and Eukaryo6c cells • Designing of primers and PCR amplificaon of specific gene sequences • The issue of alternave reading frames and gain of toxicity • Summary & Conclusions Solving Protein Crystal Structures Using NSLS-2 Background • Expression of cloned genes in prokaryotic and eukaryotic host cells achieves dual purpose: • Study of gene function • Production of substantial amounts of products for commercial & investigational use. • Scientific efforts are geared towards establishing strategies to determine appropriate vector-host combination for expression of an exogenous gene • This is based on many factors that relate ultimately to nature, source and the properties of the gene and its product. • Currently, there is a problem of compatibility of vector-host combination in reaching the maximum amount of expression of a particular gene • Proper translation of mRNA transcript is critical to ensure proper folding of the product, and to sustain the protein in the intact and functional state. The Vector & Host Choice: Eschrichia coli Model Expression System Developed in 1986 by W. F. Studier and B. A. Moffa at BNL • They created an RNA polymerase expression system which was highly selective for bacteriophage T7 RNA polymerase. • It was designed to produce many copies of a desired protein within a host cell. • Recombinant expression vector is inserted (transformed) into a host cell.
    [Show full text]